WallStSmart
ORMP

Oramed Pharmaceuticals Inc

NASDAQ: ORMP · HEALTHCARE · BIOTECHNOLOGY

$3.88
+1.04% today

Updated 2026-04-30

Market cap
$163.00M
P/E ratio
2.69
P/S ratio
81.50x
EPS (TTM)
$1.50
Dividend yield
52W range
$2 – $4
Volume
0.1M

Oramed Pharmaceuticals Inc (ORMP) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+0.0%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+198.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+3.0%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+6.9%
2025-11-17
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-25$0.25+412.5%$3.46$3.43-0.9%
2025-11-17$0.15+475.0%$2.33$2.49+6.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.08$0.25+412.5%
2025-09-30$-0.04$0.15+475.0%
2025-06-30$-0.01$0.31+3200.0%
2025-03-31$-0.05$-0.19-280.0%$2.00M
2024-12-31$0.02$-0.26-1376.0%
2024-09-30$0.04$-0.48-1300.0%
2024-06-30$0.01$0.26+2500.0%
2024-03-31$0.02$0.04+100.0%
2023-12-31$-0.12$0.33+375.0%
2023-09-30$-0.08$-0.08+0.0%
2023-06-30$-0.10$-0.03+70.0%$674000.00
2023-03-31$-0.26$-0.08+69.2%$666000.00
2022-12-31$-0.23$-0.22+4.3%

Frequently asked questions

Has Oramed Pharmaceuticals Inc beaten earnings estimates?
Oramed Pharmaceuticals Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +0.0% over the last 2 quarters.
How does ORMP stock react to earnings?
ORMP stock has moved an average of +3.0% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.